Updated August 1, 2026

NovoLog Cost Without Insurance: Novo Nordisk Savings & Cash Price (2026)

Evan Brown
Written by Evan Brown
Prescription Savings Researcher
Dr Megan Harris Medically Reviewed by Dr. Megan Harris, MD
Editorial Review: This guide explains what NovoLog actually costs without insurance in 2026, including vial and FlexPen pricing, how Novo Nordisk's two separate $35 savings programs work, and the exact steps to apply for free medication through the Patient Assistance Program.
Quick Answer

Without insurance, a 10 mL vial of NovoLog typically costs $72–$86 in cash, while a box of five 3 mL FlexPens (15 mL total) runs about $140–$165. Very few patients actually pay these amounts. Novo Nordisk's My$35Insulin program lets anyone — insured or not — pay $35 for up to 3 vials or 2 pen packs of any combination of Novo Nordisk insulin products each month, with no income check required. A separate NovoLog Savings Card caps commercially insured patients at $35 per 30-day supply. For patients who need it, the Novo Nordisk Patient Assistance Program provides NovoLog completely free to eligible patients with household income at or below 400% of the federal poverty level. Medicare Part D enrollees already have insulin capped at $35/month under federal law.

Key Takeaways

  • NovoLog's list price dropped sharply after Novo Nordisk's 2024 price cut, but retail cash prices still run $72–$165 depending on vial or pen quantity.
  • Unlike some competitors, NovoLog's authorized generic (insulin aspart) is priced about the same as the brand — it won't meaningfully lower your cost on its own.
  • My$35Insulin has no income requirement and works for anyone, insured or not, but excludes Medicare, Medicaid, and other federal coverage.
  • Medicare, Medicaid, and VA beneficiaries can't use either Novo Nordisk savings card, but Medicare already caps insulin at $35/month separately.
  • Free medication through the Novo Nordisk Patient Assistance Program requires a prescriber's signature and proof of income, and enrollment must be renewed roughly every 12 months.

NovoLog (insulin aspart) is Novo Nordisk's fast-acting mealtime insulin, used to manage blood sugar spikes around eating. It's one of the most widely prescribed rapid-acting insulins in the country, and one of the most searched terms when someone loses coverage, switches jobs, or hits a high-deductible plan early in the year.

NovoLog's pricing story shifted substantially after Novo Nordisk cut list prices on several insulins by up to 75% starting in 2024. That cut brought vial and FlexPen prices down significantly from where they sat a few years ago, but a real gap still exists between the "sticker price" at the pharmacy counter and what most patients actually end up paying once a savings program is applied.

This guide breaks down exactly what NovoLog costs at every stage, how the two separate Novo Nordisk $35 programs differ, and how to apply for free medication through the Patient Assistance Program if you need it.

What NovoLog Actually Costs Without Insurance

NovoLog is typically dispensed as a single 10 mL vial or a box of five 3 mL FlexPens (15 mL total). Cash pricing varies by pharmacy, but published pricing data consistently lands in a fairly tight range following the 2024 list-price reduction.

Form Typical Cash Price (No Discount) Typical Discount-Card Price
10 mL Vial $72–$86 $70–$80
Box of 5 FlexPens (15 mL) $140–$165 $100–$145
With My$35Insulin $35 per month for up to 3 vials or 2 pen packs, any combination
Novo Nordisk Patient Assistance $0 if income-eligible

Why the vial and FlexPen prices look close together: After Novo Nordisk's 2024 price cut, list and cash prices converged much more than they used to. A vial is still the cheapest single unit, but the gap between vial and pen pricing is smaller than it was a few years ago, so the FlexPen's convenience costs less of a premium than before.

NovoLog vs. Generic Insulin Aspart: Is There Really a Cheaper Option?

Some insulin manufacturers price their authorized generic well below the brand name. Novo Nordisk took a different approach with NovoLog.

Product Active Ingredient 10 mL Vial List Price Manufacturer
NovoLog (brand) Insulin aspart $72–$86 Novo Nordisk
Insulin Aspart (unbranded) Insulin aspart $72–$86 Novo Nordisk

This is different from some other insulins. Eli Lilly's authorized generic of Humalog sells for a fraction of the brand price, but Novo Nordisk intentionally priced its unbranded insulin aspart to match NovoLog rather than undercut it. In practice, this means asking for the generic name alone won't save you money on NovoLog — the savings programs below are where the real difference is.

NovoLog vs. Other Rapid-Acting Insulins

NovoLog competes with a handful of other mealtime insulins. Here's how it compares on cash price and manufacturer savings support.

Insulin Manufacturer Typical Cash Price (Box) Manufacturer $35 Program?
NovoLog Novo Nordisk $140–$165 Yes — NovoLog Savings Card + My$35Insulin
Fiasp Novo Nordisk $140–$165 Yes — same programs as NovoLog
Humalog Eli Lilly $150–$165 Yes — Insulin Value Program
Insulin Lispro (generic) Eli Lilly $25–$45 per vial Yes — Insulin Value Program
Admelog Sanofi $140–$160 Discount cards only

Both Novo Nordisk and Eli Lilly offer $35 manufacturer programs, so the real out-of-pocket cost between NovoLog and Humalog often ends up nearly identical once a savings card is applied — even though the underlying list prices tell a slightly different story.

The Two Novo Nordisk $35 Programs

Novo Nordisk runs two separate savings programs that both land at $35, but they're built for different situations. Confusing them is one of the most common reasons patients think they don't qualify for either.

Feature NovoLog Savings Card My$35Insulin
Who Qualifies Patients with commercial insurance Anyone — insured or uninsured
Monthly Cost $35 per 30-day supply $35 for up to 3 vials or 2 pen packs of any Novo Nordisk insulin
Maximum Savings Up to $65 per fill Not applicable — flat $35 regardless of quantity within the limit
Income Check? No No
Excluded Groups Medicare, Medicaid, and other federal programs Medicare, Medicaid, and other federal programs
Re-Enrollment Valid for up to 24 months per enrollment Required each calendar year
How to Enroll novolog.com/savings or call 1-888-668-6444 NovoCare's MyInsulinRx page or call 1-888-910-0632

Which one applies to you: If you have commercial insurance, start with the NovoLog Savings Card. If you're uninsured, between plans, or in a coverage gap, My$35Insulin is the program built specifically for that situation — and it covers any combination of Novo Nordisk insulins, not just NovoLog.

The Novo Nordisk Patient Assistance Program (Free NovoLog)

If even $35 a month is out of reach, the Novo Nordisk Patient Assistance Program (PAP), administered through NovoCare, is a separate income-based charity program that can provide NovoLog at no cost at all.

Feature Details
Cost to Patient $0 for approved medication
Who Qualifies Uninsured patients, or those enrolled in Medicare Part D
Income Limit for NovoLog At or below 400% of the Federal Poverty Level
Documentation Needed Proof of income, insurance status, a completed prescriber section, and a Medicaid denial letter for uninsured applicants
Enrollment Length Roughly 12 months for uninsured patients; through the calendar year for Medicare Part D patients
Delivery Shipped directly to your home via Neovance Specialty Pharmacy

Who typically doesn't qualify: Patients with Medicaid or VA prescription benefits are generally not eligible for the Novo Nordisk PAP, since those programs are considered adequate existing coverage. Patients with commercial insurance that already covers NovoLog are usually directed to the NovoLog Savings Card instead.

Eligibility Comparison: Savings Programs vs. Patient Assistance

Situation NovoLog Savings Card My$35Insulin Patient Assistance Program
No insurance, any income level Not eligible Eligible Eligible only if income ≤ 400% FPL
Commercial insurance covering NovoLog Eligible Eligible Not eligible
Medicare Part D Not eligible Not eligible Eligible if income ≤ 400% FPL
Medicaid Not eligible Not eligible Generally not eligible
Household income above 400% FPL, no insurance Not eligible Eligible Not eligible

Income Limit Comparison (2026 FPL Guidelines)

The Novo Nordisk PAP ties NovoLog's income limit to 400% of the Federal Poverty Level, the same tier used for other Novo Nordisk insulins like Levemir and Tresiba. Here's what that looks like for the 48 contiguous states — Alaska and Hawaii use higher figures, so call for exact numbers if you live in either state.

Approximate 2026 annual household income limits at 400% FPL
Household Size 400% FPL (NovoLog/Insulin Tier)
1 Person ~$63,840
2 People ~$86,720
3 People ~$109,600
4 People ~$132,480

My$35Insulin and the NovoLog Savings Card have no income limit at all. The 400% FPL threshold applies only to the Patient Assistance Program. If your income is above that limit but you're uninsured, the savings card programs are still available to you.

Covered Medications Comparison

It helps to see where NovoLog sits relative to other Novo Nordisk products, since some patients managing diabetes are also on a GLP-1 medication or a long-acting insulin with different program rules.

Program NovoLog Status Other Novo Nordisk Insulins Included Income Check Required?
My$35Insulin Covered Fiasp, Levemir, Tresiba, NovoLog Mix, Novolin No
Patient Assistance Program (Insulin Tier) Covered — free if eligible Fiasp, Levemir, Tresiba Yes — 400% FPL
Patient Assistance Program (Ozempic Tier) Not in this tier Ozempic (uninsured only, ≤200% FPL) Yes — 200% FPL
Medicare Part D Insulin Cap Covered Any covered insulin on your plan's formulary No — automatic

Pros and Cons of Each Savings Option

My$35Insulin — Pros

  • No income documentation or insurance required
  • Covers any combination of Novo Nordisk insulins, not just NovoLog
  • Simple online registration, download card immediately
  • Available every month during the calendar year

My$35Insulin — Cons

  • Not available to Medicare, Medicaid, or VA patients
  • Requires re-enrollment every calendar year
  • Still costs $35 every month, not free
  • Capped at 3 vials or 2 pen packs per month

Patient Assistance Program — Pros

  • Medication is completely free if approved
  • Works for Medicare Part D patients
  • Covers roughly a 12-month enrollment period
  • Shipped directly to your home once approved

Patient Assistance Program — Cons

  • Requires proof of income and a prescriber signature
  • Uninsured applicants also need a Medicaid denial letter
  • Processing takes longer than a savings card
  • Must be renewed annually with updated documents

Real-World Cost Examples

Example 1: Uninsured, using one FlexPen box every two months

Maria is uninsured and fills one box of NovoLog FlexPens (5 pens) roughly every two months. Without any discount, that's about $140–$165 every other month, or roughly $840–$990 a year.

With My$35Insulin, each fill drops to $35. Annual cost: about $210 instead of $840–$990.

Example 2: Commercially insured, high deductible

James has commercial insurance with a high deductible, so his pharmacy quotes him the full $140–$165 cash price early in the plan year before his deductible is met. He enrolls in the NovoLog Savings Card instead.

Result: His cost drops to $35 per fill for up to 24 months, regardless of his deductible status.

Example 3: Low-income, uninsured, applying to the PAP

Denise is uninsured, supports a household of two, and earns $38,000 a year — well under the ~$86,720 limit for a two-person household. She applies to the Novo Nordisk PAP with her prescriber's help, including a Medicaid denial letter.

Once approved, NovoLog ships to her home at no cost for a roughly 12-month enrollment period. Annual cost: $0, instead of roughly $840–$990 at cash price.

How to Apply, Step by Step

Enrolling in the NovoLog Savings Card (Commercially Insured)

1

Visit the enrollment page

Go to novolog.com/savings or call 1-888-668-6444 to enroll. You'll need basic insurance information on hand.

2

Download or print your card

Once registered, you can download a digital card or print a physical one to bring to the pharmacy.

3

Present it at the pharmacy counter

Confirm with the pharmacist that the $35 price was applied before you pay.

Enrolling in My$35Insulin (Any Insurance Status)

1

Register online or by phone

Visit NovoCare's MyInsulinRx page or call 1-888-910-0632 to sign up. No income documentation is required.

2

Download your card

The card is available immediately after registration and can be used the same day.

3

Re-enroll each calendar year

Mark your renewal date so the card doesn't lapse when the new year starts.

Applying for the Novo Nordisk Patient Assistance Program

1

Get the application

Download the application at novocare.com or call the program directly to have one sent to you.

2

Complete the patient section

Fill in household size, income, and current insurance status accurately — mismatches here are the most common reason applications stall.

3

Have your prescriber complete their section

Your doctor confirms the diagnosis, medication, dose, and signs the form.

4

Attach proof of income and a Medicaid denial letter if uninsured

A recent tax return, pay stub, or Social Security statement typically satisfies the income requirement.

5

Submit the completed application

Applications are typically submitted online for the fastest processing, though fax and mail options exist.

6

Await written notification

Both you and your prescriber will receive confirmation of approval or denial, along with delivery instructions if approved.

Decision Tree: Which Option Fits You

Step 1: Do you have Medicare, Medicaid, or VA benefits?

This determines which savings tool you can even use.

Yes — Government Coverage

Check your plan's insulin cap

Medicare Part D and Medicare Advantage already cap insulin at $35/month by law.

Income ≤ 400% FPL?

If yes, the Novo Nordisk PAP can make NovoLog fully free instead.

No — Commercial or Uninsured

Do you have commercial insurance?

If yes, use the NovoLog Savings Card. If not, use My$35Insulin.

Still can't afford $35/month?

Apply to the Novo Nordisk PAP if income ≤ 400% FPL.

Approval Timelines

Program Typical Timeline
NovoLog Savings Card Immediate — download and use the same day
My$35Insulin Immediate — register online and use right away
Patient Assistance Program (complete application) 1–2 business days for online applications
Patient Assistance Program (missing documents) Delayed until resubmitted, often adding a week or more
Medicare insulin cap Automatic — no application needed

Renewing Your Enrollment

  • My$35Insulin requires re-enrollment every calendar year — mark early January on your calendar so the card doesn't lapse.
  • The NovoLog Savings Card is valid for up to 24 months per enrollment, so check your original sign-up date to know when renewal is due.
  • The Patient Assistance Program runs roughly 12 months for uninsured patients, or through the calendar year for Medicare Part D patients, after which reapplication is required.
  • Report any change in insurance or income right away — gaining new coverage can end PAP eligibility mid-cycle.

Common Mistakes That Cost You Money

  • Assuming the generic "insulin aspart" name will lower your NovoLog price the way it does for some other brands.
  • Trying to use the NovoLog Savings Card without commercial insurance — it's not the right program for uninsured patients.
  • Assuming Medicare patients can use either Novo Nordisk savings card (they can't — Medicare has its own separate cap).
  • Letting My$35Insulin lapse at the start of the year by forgetting to re-enroll.
  • Submitting a Patient Assistance Program application without the Medicaid denial letter if uninsured.
  • Waiting until the current PAP enrollment has already lapsed before starting renewal.
  • Other Ways to Save on NovoLog

    If none of Novo Nordisk's own programs fit your situation, a few additional options are worth exploring:

    • State insulin price-cap laws: More than 25 states cap monthly out-of-pocket insulin costs for state-regulated commercial plans, though these caps generally don't apply to self-funded employer plans under federal ERISA rules.
    • Pharmacy discount programs: Comparing GoodRx and Inside Rx pricing before filling can sometimes beat the list price even without a manufacturer card.
    • NeedyMeds and BenefitsCheckUp: Independent, non-manufacturer databases that can surface additional assistance programs based on your ZIP code and diagnosis.
    • State Pharmaceutical Assistance Programs: Several states run supplemental drug coverage for eligible residents, layered on top of Medicare or private insurance.

    Managing more than one prescription? Our Drug Price Checker compares cash and discount-card pricing across pharmacies near you in seconds, and our insulin savings programs guide and manufacturer savings card guide cover how NovoLog's programs stack up against other insulins.


    Bottom Line

    NovoLog's cash price without insurance — $72–$86 for a vial, or $140–$165 for a standard FlexPen box — is almost never what patients actually end up paying. My$35Insulin covers nearly everyone regardless of insurance status, with no income documentation required, while the NovoLog Savings Card handles commercially insured patients specifically. For patients who need it, the Novo Nordisk Patient Assistance Program can bring the cost to zero, provided household income falls at or below 400% of the federal poverty level.

    The step that actually determines your out-of-pocket cost isn't finding a program — it's confirming which one applies to your specific insurance status before you pay full price at the register.

    Ready to lower your NovoLog cost?

    Call NovoCare at 1-888-668-6444 for the NovoLog Savings Card, or 1-888-910-0632 for My$35Insulin, regardless of insurance status.

    Go to NovoCare → See Required Documents

    Frequently Asked Questions

    A 10 mL vial of NovoLog typically costs $72 to $86 in cash without insurance, while a box of five 3 mL FlexPens (15 mL total) runs about $140 to $165. Most patients don't pay this, since Novo Nordisk's My$35Insulin program caps a monthly supply at $35 regardless of insurance status.

    Novo Nordisk sells an unbranded version called insulin aspart injection 100 units/mL, but unlike some other insulin generics, Novo Nordisk priced it to match branded NovoLog rather than undercut it. Switching to the generic name alone won't meaningfully lower your cost — a savings card or the Patient Assistance Program will make a bigger difference.

    Yes. Novo Nordisk's My$35Insulin program lets anyone, insured or not, pay $35 for up to 3 vials or 2 pen packs of any combination of Novo Nordisk insulin products each month, with no income documentation required. It requires re-enrollment each calendar year and does not apply to Medicare, Medicaid, or other federal insurance.

    Uninsured patients, or those on Medicare Part D, whose household income falls at or below 400% of the federal poverty level can typically get NovoLog at no cost through the Novo Nordisk Patient Assistance Program. The application requires a prescriber signature, proof of income, and for uninsured applicants, a Medicaid denial letter.

    Most Medicare Part D and Medicare Advantage drug plans cover NovoLog, and under current federal law, out-of-pocket costs for covered insulins are capped at $35 for a month's supply, regardless of your plan's deductible. Coverage still varies by plan, so it's worth checking your specific formulary. See our Medicare Part D insulin coverage guide for details.

    The NovoLog Savings Card is for patients with commercial insurance and caps a 30-day supply at $35, with savings of up to $65 per fill. My$35Insulin is a separate program open to anyone regardless of insurance status, capping a monthly supply of any Novo Nordisk insulin at $35. Neither works with Medicare, Medicaid, or other federal coverage.

    You likely won't qualify for the Novo Nordisk Patient Assistance Program, but you can still use My$35Insulin regardless of income, since that program has no income requirement at all.

    No. These are separate programs designed for different situations — the savings program reduces a cash price, while the PAP replaces that price entirely with free medication. You'd use one or the other based on your income and insurance status, not both at once.

    No, as long as your total monthly need stays within 3 vials or 2 pen packs. If your prescribed dose requires more than that limit in a single month, talk to your prescriber's office about how to structure your fills or whether the Patient Assistance Program might be a better fit.

    Report the change to the program as soon as it happens. Gaining insurance that adequately covers NovoLog can end your PAP eligibility before your enrollment period is up, so it's important to update your status rather than wait for renewal.

    Independent databases like NeedyMeds and BenefitsCheckUp let you search for state, nonprofit, and disease-specific assistance programs by ZIP code, separate from any single manufacturer's offerings.


    How We Researched This Guide

    This guide was prepared by the Refill Relay Editorial Team using publicly available manufacturer pricing and patient assistance documentation from Novo Nordisk and NovoCare, current federal poverty level guidelines, and standard Medicare Part D insulin cost protections.

    Every article undergoes editorial review for accuracy, readability, and consistency before publication. Our goal is to explain insulin affordability programs in clear language so patients and caregivers can access their medication with less friction.


    References

    1. Novo Nordisk. NovoCare Patient Support and Cost Assistance Overview.
    2. Novo Nordisk. NovoLog Insurance and Savings Card Terms.
    3. U.S. Department of Health and Human Services. Federal Poverty Level Guidelines.
    4. Medicare.gov. Insulin Coverage and Cost Protections Under Part D.
    5. Centers for Medicare & Medicaid Services. Medicare Part D Insulin Cap Guidance.
    6. U.S. Food and Drug Administration. NovoLog Prescribing Information.
    7. NeedyMeds. Independent Patient Assistance Program Directory.
    8. National Council on Aging. BenefitsCheckUp Assistance Program Search.
    9. Lilly Cares Foundation. Patient Assistance Program Overview (Comparison Reference).

    About Refill Relay

    Refill Relay publishes evidence-based educational resources that help patients understand prescription insurance, patient assistance programs, pharmacy benefits and medication access. Our editorial team combines manufacturer program research with practical guidance to make complex healthcare topics easier to navigate.

    Editorial Standards

    • Evidence-based program research
    • Editorial review before publication
    • Regular updates when program eligibility rules change
    • Clear distinction between educational content and medical or financial advice

    Related Resources

    Editorial Policy: Refill Relay content is researched using publicly available manufacturer patient assistance program materials, federal poverty guidelines, and standard industry application practices. Every article is reviewed for clarity, accuracy and usefulness before publication.

    Evan Brown
    About the Author
    Evan Brown — Prescription Savings Researcher

    Evan Brown is a prescription savings researcher who specializes in translating complex healthcare policy — including manufacturer patient assistance programs — into clear, actionable guidance for patients.

    View Full Profile →
    Dr. Megan Harris, MD
    Medical Review
    Dr. Megan Harris, MD — Board-Certified Internal Medicine

    Dr. Megan Harris, MD reviews health content for accuracy, checking eligibility criteria and program documentation practices against current manufacturer and CMS guidance.

    View Full Profile →

    Contact Refill Relay